← Open Payments lookup

JUSTIN LETOURNEAU: Open Payments

NPI 1861710923 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,209 in 59 payments from 16 companies in 2025. Trend: 2023 $178 · 2024 $1,128 · 2025 $1,209

Food & beverage: $1,209
CompanyPaymentsAmount
ABBVIE INC.11$226
Otsuka America Pharmaceutical, Inc.9$172
Axsome Therapeutics, Inc.6$128
Noven Therapeutics, LLC7$126
Takeda Pharmaceuticals U.S.A., Inc.4$101
Neurocrine BioSciences, Inc.3$75
Vanda Pharmaceuticals Inc.3$69
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$68
Janssen Pharmaceuticals, Inc3$52
Teva Pharmaceuticals USA, Inc.2$48

Products named: VRAYLAR, REXULTI, Auvelity, Xelstrym, TRINTELLIX, INGREZZA, FANAPT, CAPLYTA.

Industry payments across FL — which companies pay providers there.